Boosting Chemodynamic Therapy via a Synergy of Hypothermal Ablation and Oxidation Resistance Reduction

Junlie Yao,Fang Yang,Fang Zheng,Chenyang Yao,Jie Xing,Xiawei Xu,Aiguo Wu
DOI: https://doi.org/10.1021/acsami.1c16835
2021-11-15
Abstract:Chemodynamic therapy (CDT), deemed as a cutting-edge antineoplastic therapeutic tactics, efficaciously suppresses tumors <i>via</i> catalytically yielding hydroxyl radicals (<sup>•</sup>OH) in tumor regions. Nevertheless, its biomedical applications are often restricted by the limited hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) level and upregulated antioxidant defense. Herein, a versatile nanoreactor is elaborately designed <i>via</i> integrating Cu<sub>2-<i>x</i></sub>S and MnO<sub>2</sub> for <i>T</i><sub>1</sub>-weighted magnetic resonance (MR) imaging-guided CDT, synergistically enhanced through hypothermal ablation and oxidation resistance reduction, thereby displaying splendid antitumor efficiency as well as suppression on pulmonary metastasis. The as-synthesized Cu<sub>2-<i>x</i></sub>S@MnO<sub>2</sub> nanoreactors afford acid-dependent Cu-based and glutathione (GSH)-activated Mn-based catalytic properties for bimodal CDT. Owing to excellent absorbance at the second near-infrared (NIR-II) window, the Cu<sub>2-<i>x</i></sub>S furnishes hypo-photo-thermal therapy (PTT) against tumor growth and ameliorates the catalytic performance for thermal-enhanced CDT. Additionally, MnO<sub>2</sub> significantly downregulates GSH and glutathione peroxidase 4, which synergistically boosts CDT <i>via</i> promoting oxidative stress, simultaneously generating Mn<sup>2+</sup> for MR contrast improvement and activatable tumor imaging. Therefore, this study proffers a new attempt centered on the collaborative strategy integrating NIR-II hypothermal PTT and synergistically enhanced CDT for tumor eradication.
materials science, multidisciplinary,nanoscience & nanotechnology
What problem does this paper attempt to address?